SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-21-006071
Filing Date
2021-05-06
Accepted
2021-05-06 07:16:11
Documents
3
Period of Report
2021-05-06

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20210506x6k.htm 6-K 21085
2 EX-99.1 tmb-20210506xex99d1.htm EX-99.1 477997
3 EX-99.2 tmb-20210506xex99d2.htm EX-99.2 419398
  Complete submission text file 0001558370-21-006071.txt   919511
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 21895775
SIC: 2834 Pharmaceutical Preparations